TrialCancer science2015

Randomized phase II/III clinical trial of elpamotide for patients with advanced pancreatic cancer: PEGASUS-PC Study.

Hiroki Yamaue et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.